Clinical Trial: Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481773) titled 'Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU' on Feb. 24.

Brief Summary: The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.

Study Start Date: May 13, 2025

Study Type: INTERVENTIONAL

Condition: Intensive Care Unit (ICU) Admission

Intervention: DIAGNOSTIC_TEST: Biomarker-signature supported antibiotic treatment recommendation

The antibiotic treatment recommendation will be based on a decision matrix that combines the results of...